S. Négrier

Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC)

Robert A. Figlin, Thomas E. Hutson, Piotr Tomczak et al. · Journal of Clinical Oncology · 2008 · 167 citations

Cancer Management, Sunitinib Versus Interferon, First-line Treatment +17

Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma

Marie Paule Sablin, S. Négrier, Alain Ravaud et al. · The Journal of Urology · 2009 · 154 citations

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

Revathi Suppiah, Philip Shaheen, Paul Elson et al. · Cancer · 2006 · 95 citations · Full text

Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-α to patients with advanced renal cell carcinoma

J. W. Smith, Yoo-Joung Ko, J. Dutcher et al. · Journal of Clinical Oncology · 2004 · 17 citations

Renal Pathology, Renal Inflammation, Pharmacotherapy +16

[Adverse effects of interleukin 2].

Alain Ravaud, S. Négrier, F Lakdja et al. · PubMed · 1991 · 12 citations